首页> 外文期刊>Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology >Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.
【24h】

Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.

机译:升级到右心室起搏性充血性心力衰竭患者的双心室起搏/除颤系统:程序参数和反应率的前瞻性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: Cardiac resynchronization therapy (CRT) is indicated in patients with heart failure and bundle branch block. It is less clear whether this includes patients with pre-existing right ventricular pacemaker/defibrillator systems, particularly with respect to implantation success and clinical benefit. METHODS AND RESULTS: In consecutive patients scheduled for CRT, we prospectively compared implantation success, procedural parameters, and clinical response in 'de novo' vs. upgrade procedures of previously implanted right ventricular systems. CRT implantation was attempted in 79 consecutive patients (64 +/- 11 years, 63 male, 38 ischaemic, 41 non-ischaemic cardiomyopathy). De novo implantation was performed in 61 patients, upgrade procedures in 18 patients. Implant success (92 vs. 94%, P = 1.00), procedure duration (153 +/- 43 vs. 164 +/- 65 min, P = 0.51), fluoroscopy time (25 +/- 18 vs. 32 +/- 22 min, P = 0.18) or dose (40 +/- 31 vs. 52 +/- 49 Gy/cm(2), P = 0.35), and response rate (66 vs. 59%, P = 0.5) were comparable for both groups. CONCLUSION: Procedural aspects, implantation success, and clinical response to CRT were comparable for patients undergoing de-novo vs. upgrade procedures. Accordingly, patient selection for upgrading should be the same as for new CRT implantation.
机译:目的:心力衰竭和束支传导阻滞的患者应进行心脏再同步治疗(CRT)。目前尚不清楚这是否包括已存在右心室起搏器/除颤器系统的患者,特别是在植入成功和临床获益方面。方法和结果:在预定进行CRT的连续患者中,我们前瞻性比较了先前植入右心室系统的“从头开始”与升级过程的植入成功率,手术参数和临床反应。连续79名患者(64 +/- 11岁,男性63例,缺血38例,非缺血性心肌病41例)尝试进行CRT植入。从头植入61例,升级程序18例。植入成功率(92%对94%,P = 1.00),手术时间(153 +/- 43对164 +/- 65分钟,P = 0.51),透视时间(25 +/- 18对32 +/- 22分钟(P = 0.18)或剂量(40 +/- 31 vs. 52 +/- 49 Gy / cm(2),P = 0.35)和缓解率(66 vs. 59%,P = 0.5)是可比的对于两个群体。结论:在接受新式与升级程序治疗的患者中,程序方面,植入成功率和对CRT的临床反应相当。因此,用于升级的患者选择应与新的CRT植入相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号